Latest from Almac
April 25th, 2019
Almac Group Launches TempEZ™ Site Storage Temperature Compliance Module
April 18th, 2019
Almac Group Partner with Queen’s Researchers to pioneer potentially life-changing oesophageal cancer test
April 15th, 2019
Almac Group Further Expands Global Analytical Services Capability
October 16th, 2018
Almac Launches Brexit Resource Hub
Partnering to advance human healthExplore our locations
Brexit - A Seamless Solution
Almac recognizes that you need bespoke solutions to suit your needs. Only we can combine the expertise from our world leading range of specialized drug development services to support you across the full biopharmaceutical product lifecycle, from the preclinical stages through to commercialization.
Almac Diagnostic Services is our stratified medicine business unit, specializing in biomarker driven clinical trials. Our global laboratories, in the UK and US, offer tailored solutions from discovery to commercialization: biomarker discovery, assay development & validation, CDx development & commercialization. Your clinical trial diagnostic partner.
Almac Discovery is a research driven, oncology business unit within Almac dedicated to the discovery and development of novel, innovative approaches to the treatment of cancer. We focus on early stage development and partner programs with the pharmaceutical industry at the discovery to preclinical stage.
Global Clinical Supplies Group (GCSG) Annual Conference 2019
28 April 2019 San Antonio, TX
ARVO 2019 Annual Meeting
28 April 2019 Vancouver, BC
5th Annual Formulation & Drug Delivery Congress
29 April 2019 London, UK
CPhI North America
30 April 2019 Chicago, IL